STAT+: Pharmalittle: We’re reading about a Roche obesity drug, an experimental Lilly insulin, and more
Top of the morning to you, and a fine one it is, despite the gray…
Category: STAT+
.jpg)
STAT+: Biogen, Ionis drop ALS treatment after study failure
A plan to use new genetic techniques to treat non-genetic forms of ALS failed in…
.jpg)
STAT+: Lilly’s weekly insulin works as well as daily products, new studies show
Eli Lilly reported Thursday that its experimental weekly insulin worked as well as daily basal…
STAT+: Obesity drug from Roche succeeds in early test, sending company shares up
LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose…
STAT+: Galapagos, in makeover mode, strikes deal to make CAR-T therapies at blood centers across U.S.
Seeking to differentiate itself from other makers of CAR-T cancer therapies, Galapagos NV on Wednesday…
STAT+: WuXi Biologics execs register to lobby as Congress comes for the company
WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a…
STAT+: Getting abortion pills through the mail is safe, quick, and effective, study finds
Amid a national furor over access to abortion, a new study found that dispensing abortion…
STAT+: Pharmalittle: We’re reading about fake studies, AbbVie investing in psychedelics, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Abbott’s dissolvable stent, which failed in heart disease patients, may help vascular patients
An Abbott device that failed in heart disease patients is getting a new life in…
STAT+: Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drug
A U.S. lawmaker is accusing Amgen of “putting profits before patients” over its decision to…
STAT+: CVS is willing to dump 10% of its Medicare Advantage members next year
CVS Health is preparing to make significant changes to its 2025 Medicare Advantage plans, which…
STAT+: The White House hikes tariffs on Chinese medical products
WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of…
STAT+: Novo to test Wegovy and other obesity drugs against alcohol-related liver disease
Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease,…
STAT+: Pharmalittle: We’re reading about Pfizer’s DTC platform, Sandoz’s feud with a U.K. trade group, and more
Rise and shine, everyone, another busy day is on the way. We can tell thanks…
STAT+: Element Biosciences, an Illumina rival, on its genomics ambitions — and why it hasn’t gone public
SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit…
STAT+: Cue Health’s Covid-19 tests could give false results, FDA warns
The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19…
STAT+: Sandoz leaves U.K. trade group over dispute about promoting a biosimilar for multiple sclerosis
In an unusual move, Sandoz is no longer cooperating with a U.K. industry trade group…
STAT+: The stories that shaped our understanding of the health care system
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Late-stage results set up Cytokinetics heart drug to compete with Bristol
Late-stage results of Cytokinetics’ drug for a rare heart disease suggest it can compete with…
STAT+: Pharmalittle: We’re reading about FDA dithering on pharma patents, WHO pandemic talks, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: FDA is criticized for taking a ‘ministerial’ role in sorting out some pharma patents
When it comes to a crucial controversy over pharmaceutical patents, the FDA has been MIA….
STAT+: Can AI build custom ‘n-of-1’ drugs faster? Maybe not yet, new case study suggests
Two years ago, Yiwei Shi was searching desperately for someone to build a drug for…
STAT+: First recipient of kidney transplant from genetically engineered pig has died, family says
Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has…
STAT+: Harvard scientists unveil the most detailed map of the brain ever: ‘It’s an alien world inside your own head’
About 10 years ago, a small piece of human brain arrived in the lab of…
STAT+: Pharmalittle: We’re reading about Sanofi licensing Novavax’s Covid shot, Moderna’s RSV vaccine, and more
Hello there and happy Friday from STAT’s London outpost, where the weekend is mere hours…
STAT+: CRISPR edits fail to cure HIV patients in early test
BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in…
STAT+: After its last deal fell through, a rare disease therapy gets a second chance with Shionogi
After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics…
STAT+: Sanofi enters vaccine licensing deal with Novavax, giving beleaguered biotech a lifeline
LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of…
STAT+: No, alcohol isn’t good for you. Will new dietary guidelines be shaped more by health or industry interests?
In 1995, when Marion Nestle was on the committee drafting the Dietary Guidelines for Americans,…
Exact Sciences’ stock tumbles amid worries cancer detection firm’s growth may slow
Exact Sciences reported first-quarter revenues this week that beat market expectations, and the cancer detection…
STAT+: Health care leaders plot how to expand diversity in clinical trials
Even with the recent awareness that clinical trials often lack the diversity that would make…
STAT+: Cytokinetics set to pitch its heart drug to physicians — and Big Pharma suitors
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers…
STAT+: Pharmalittle: We’re reading about Takeda restructuring, Pfizer settling Zantac suits, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says
U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for…
STAT+: Getting Alzheimer’s treatment to those who need it poses particular challenges
A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts…
STAT+: A nonprofit does deals in Brazil and India to make low-cost CAR-T cell therapies widely available
In the latest bid to widen access to medicines, a nonprofit is sending technology and…
STAT+: Software glitch caused Tandem insulin pumps to prematurely shut down, FDA warns
At least 224 diabetes patients have been harmed by a software error causing their insulin…
STAT+: In fundamental advance, Google says AlphaFold 3 can map a vast universe of biomolecules
Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction…
STAT+: Pharmalittle: We’re reading about a boy dying in Pfizer trial; AstraZeneca yanking Covid shot, and more
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
STAT+: Apple pushes into clinical trials with new FDA nod for Apple Watch
The Apple Watch has secured a new qualification from the Food and Drug Administration that…
STAT+: Endo Health ordered to pay more than $1.5 billion in opioid criminal case
In the second-largest fine ever levied on a pharmaceutical company, Endo Health Solutions was ordered…
STAT+: Life science leaders on how to make drug development less expensive, slow, and risky
Drug development is essentially a long, expensive bet: Ninety percent of drugs fail during clinical…
STAT+: Young boy dies in trial for Pfizer Duchenne gene therapy
A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular…
STAT+: House panel eyes PBM reform to pay for telehealth extensions
A new bill set to be considered on Wednesday by the House Ways & Means…
STAT+: Assistants, not replacements: How AI can accelerate research and health care
When patients are dealing with a sexually transmitted infection, they don’t always get advice on…
STAT+: Pharmalittle: We’re reading about MDMA for PTSD, a CRISPR treatment for blindness, and more
Top of the morning to you, and a fine one it is. There is nothing…
STAT+: Alzheimer’s risk gene APOE4 may cause a distinct form of the disease, study suggests
For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic…
STAT+: UnitedHealth CEO downplays his company’s control over physicians
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Steward files for bankruptcy, leaving its eight Massachusetts hospitals in limbo
Steward Health Care, which once trumpeted its community hospital system as a low-cost alternative to…
STAT+: Pharmalittle: We’re reading about FTC reviewing Novo-Catalent deal, Amneal opioid settlement, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…